155 results on '"Yamaji, Hirosuke"'
Search Results
2. Optimal prevention method of phrenic nerve injury in superior vena cava isolation: efficacy of high-power, short-duration radiofrequency energy application on the risk points
3. Atrial Fibrillation Ablation Outcomes and Heart Failure (from the Kansai Plus Atrial Fibrillation Registry)
4. Catheter Ablation for Paroxysmal Atrial Fibrillation With Sick Sinus Syndrome: Insights From the Kansai Plus Atrial Fibrillation Registry
5. Rates of atrial flutter occurrence and cavotricuspid isthmus reconduction after prophylactic isthmus ablation performed during atrial fibrillation ablation: a clinical study, review, and comparison with previous findings
6. Real-World Safety Profile of Atrial Fibrillation Ablation Using a Second-Generation Cryoballoon in Japan: Insight From a Large Multicenter Observational Study
7. Long-term efficacy and safety of anticoagulation after atrial fibrillation ablation: data from the JACRE registry
8. Efficacy and safety of a novel temperature‐controlled catheter for cavotricuspid isthmus ablation.
9. Borg’s exertion scale did not coincide with ventilatory anaerobic threshold in atrial fibrillation patients with restored sinus rhythm after ablation
10. Incidence of nausea/vomiting following propofol sedation with adaptive servo‐ventilation for atrial fibrillation ablation
11. Efficacy of an Adjunctive Electrophysiological Test-Guided Left Atrial Posterior Wall Isolation in Persistent Atrial Fibrillation Without a Left Atrial Low Voltage Area
12. Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation
13. Abstract 17296: Arrhythmia Recurrence and Subsequent Heart Failure Hospitalization in Atrial Fibrillation Patients Undergoing Catheter Ablation: A Landmark Analysis From the Kansai Plus Atrial Fibrillation (KPAF) Registry
14. Effects of oral anticoagulants on ≥90-year-old atrial fibrillation patients: comparison among direct oral anticoagulant, warfarin anticoagulant, and non-anticoagulation
15. Adjunctive left anterior line ablation induced left atrial dysfunction and dyssynchrony in atrial fibrillation ablation
16. Effects of Oral Anticoagulants on Patients With Atrial Fibrillation Aged 90 Years and Older: Comparison Among Direct Oral Anticoagulant, Warfarin Anticoagulant, and Nonanticoagulation
17. Small solitary atrial fractionated electrogram zone as a novel ablation target for persistent atrial fibrillation
18. Optimal prevention method of phrenic nerve injury in superior vena cava isolation: efficacy of high-power, short-duration radiofrequency energy application on the risk points
19. Adequate Initial Heparin Dosage for Atrial Fibrillation Ablation in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants
20. Catheter Ablation for Paroxysmal Atrial Fibrillation With Sick Sinus Syndrome: Insights From the Kansai Plus Atrial Fibrillation Registry
21. Abstract 18972: Gender Differences in the Efficacy and Outcome of Atrial Fibrillation Ablation: Insights From the Kansai Plus Atrial Fibrillation (KPAF) Registry
22. Abstract 17014: Prognosis of Patients With Reduced Left Ventricular Function Undergoing Catheter Ablation for Atrial Fibrillation: From Kansai Plus Atrial Fibrillation (KPAF) Registry
23. Potential of a Novel Chemical Compound Targeting Matrix Metalloprotease-13 for Early Osteoarthritis: An In Vitro Study
24. Safety and Efficacy of Underdosing Non-vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Catheter Ablation for Atrial Fibrillation
25. Potential of a Novel Chemical Compound Targeting Matrix Metalloprotease-13 for Early Osteoarthritis: An In Vitro Study
26. 心不全を合併した心房細動患者のカテーテルアブレーション後の長期予後 : 左室駆出率に基づいた心不全のサブタイプ間における比較
27. Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation
28. Rates of atrial flutter occurrence and cavotricuspid isthmus reconduction after prophylactic isthmus ablation performed during atrial fibrillation ablation: a clinical study, review, and comparison with previous findings
29. Association of corrected QT dispersion with symptoms improvement in patients receiving cardiac resynchronization therapy
30. SEX DIFFERENCES IN CATHETER ABLATION OUTCOME AND HEART FAILURE IN ATRIAL FIBRILLATION PATIENTS: INSIGHTS FROM THE KANSAI PLUS ATRIAL FIBRILLATION REGISTRY
31. Adaptive-servo ventilation combined with deep sedation is an effective strategy during pulmonary vein isolation
32. Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
33. Sufficient pulmonary vein image quality of non-enhanced multi-detector row computed tomography for pulmonary vein isolation by catheter ablation
34. Sex differences in atrial fibrillation ablation outcomes: insights from a large-scale multicentre registry
35. Correlation of the peak oxygen consumption and ventilatory aerobic threshold by cardiopulmonary exercise testing with atrial fibrillation recurrences after ablation in patients with paroxysmal atrial fibrillation
36. LONG-TERM INCIDENCE OF THROMBOEMBOLISM AND MAJOR BLEEDING IN PATIENTS WHO UNDERWENT CATHETER ABLATION FOR ATRIAL FIBRILLATION: JACRE-EX REGISTRY
37. Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction.
38. Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes
39. Adjunctive left anterior line ablation induced left atrial dysfunction and dyssynchrony in atrial fibrillation ablation
40. Differences in activated clotting time and initial heparin dosage during atrial fibrillation ablation for patients with edoxaban compared with warfarin
41. Adjunctive interpulmonary isthmus ablation has no added effects on atrial fibrillation recurrence
42. Efficacy of 3D Pulmonary Vein Image Acquired Non-Enhanced MDCT in Patients with Chronic Kidney Disease without Dialysis who Underwent Atrial Fibrillation Ablation
43. Impact of Olmesartan on Progression of Coronary Atherosclerosis
44. AS-56: Impact of Olmesartan on Progression of Coronary Atherosclerosis: A Serial Volumetric Intravascular Ultrasound Analysis from the OLIVUS Trial
45. Abstract 2511: Impact of Olmesartan on Progression of Coronary Atherosclerosis; - A Serial Volumetric IVUS Analysis from the OLIVUS Trial -
46. Prone Position is Essential for Detection of Pulmonary Vein Pseudostenosis by Enhanced Multidetector Computed Tomography in Patients Who Undergo Pulmonary Vein Isolation
47. Pulmonary vein isolation for atrial fibrillation in young patients
48. Impact of operator experience on the duration and outcome of pulmonary vein antrum isolation for atrial fibrillation
49. The need for atrial flutter ablation following pulmonary vein antrum isolation in patients with and without previous cardiac surgery
50. ST-segment re-elevation unrelated to left ventricular ejection fraction or volume after anterior wall acute myocardial infarction treated with successful reperfusion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.